What is Beta Bionics®?

Beta Bionics® is a clinical stage medical technology company focused on the design, development, and commercialization of its iLet® Bionic Pancreas System.

Why did Beta Bionics get $100 million in funding?

The approval has likely contributed to the company securing $100 million in funding, which indicates strong investor confidence and financial backing for further development and growth. Additionally, Beta Bionics has announced the nationwide launch of the iLet Bionic Pancreas, demonstrating an expansion of its operations and market presence.

Is Beta Bionics a public benefit company?

The Bionic Pancreas was developed in an academic setting at Boston University and Mass General Hospital, though a company ultimately needs to secure FDA approval and sell it. Instead of giving the iLet to a pump company to bring to market, Dr. Damiano has ambitiously formed Beta Bionics as a dedicated public benefit corporation.